Healthcare Industry News: Bristol-Myers Squibb
News Release - May 22, 2012
Intact Vascular, LLC Hires Scott Kraus as Vice President of Sales and MarketingWAYNE, Pa.--(Healthcare Sales & Marketing Network)--Intact Vascular, LLC, today announced the appointment of Scott Kraus to the position of Vice President of Sales and Marketing. He will report directly to Carol Burns, President and CEO.
Intact Vascular CEO, Carol Burns, commented, “We are committed to recruiting the brightest personnel with a proven track record of success. We believe that Scott is the embodiment of that commitment. Mr. Kraus’s prior peripheral vascular experience and demonstrated track record for establishing and developing markets will help Intact Vascular realize its goals.”
Most recently, Mr. Kraus was Vice President of Sales with Cardiovascular Systems, Inc. where he led the efforts of a large sales organization, and drove annual revenue from $0 to $80MM. In addition, Mr. Kraus has also held sales and sales management positions for Boston Scientific Corporation, Guidant Corporation, C.R. Bard and Bristol-Myers Squibb.
Mr. Kraus received his MBA from Saint Joseph’s University Haub School of Business and his BS from Villanova University.
Mr. Kraus stated: “I am excited to take on the role of worldwide sales and marketing for Intact Vascular and developing a strategic plan for the market introduction of the Tack-IT Endovascular Stapler™”. We believe this technology will serve as a new paradigm in the treatment of peripheral artery disease by offering a solution that reduces the amount of metal used post angioplasty, minimizes chronic injury and offers versatility to the physician for spot treatment of lesions.”
About Intact Vascular
Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral artery disease which affects 8-12 million in the US. Intact Vascular is committed to developing safe and efficacious products for patients and for the physicians who use these products. Visit www.intactvascular.com for more information.
Source: Intact Vascular
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.